Description
An orally bioavailable inhibitor of PARP1 and PARP2 (IC50s = 3.8 and 2.1 nM, respectively); inhibits the proliferation of BRCA1 and BRCA2 mutant cancer cells in vitro (IC50s = 10-100 nM) and has efficacy alone against a xenograft of BRCA1-deficient cancer in mice
Formal name: 2-[4-(3S)-3-piperidinylphenyl]-2H-indazole-7-carboxamide, 4-methylbenzenesulfonate
Synonyms: Niraparib tosylate
Molecular weight: 492.6
CAS: 1038915-73-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|DNA Repair Enzymes||Research Area|Cancer|DNA Damage and Repair|PARP